Clinical Trials Browser

Completed × NIH × Prostatic Neoplasms × Clear all

NCT03388619 2026-05-27

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Phase 1 Completed

30 enrolled 16 charts

Prostatic Neoplasms

NCT02649855 2026-04-29

Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer

Phase 2 Completed

74 enrolled 15 charts

Prostatic Neoplasms

NCT03218826 2026-04-29

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Phase 1 Completed

23 enrolled 15 charts

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT03707574 2026-02-04

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

GastrointestinalGenitourinaryGynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04465214 2025-12-15

Mobile Sensor Technologies to Assess General Symptomology of People With Cancer

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms

NCT03253744 2025-10-08

Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy

Phase 1 Completed

17 enrolled 20 charts

Prostatic Neoplasms

NCT03493945 2025-09-30

Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)

Phase 1/2 Completed

59 enrolled 20 charts

Prostatic Neoplasms

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

Phase 2 Completed

43 enrolled 13 charts

GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT02769962 2025-07-28

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Phase 1/2 Completed

45 enrolled 30 charts

GenitourinaryThoracic

Carcinoma, Transitional Cell, Lung Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT02430480 2025-07-16

Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer

Phase 2 Completed

39 enrolled 21 charts

Prostatic Neoplasms

NCT00923104 2025-07-08

An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin

BreastGenitourinary

Blister, Breast Neoplasms, Prostatic Neoplasms

NCT03315871 2025-06-19

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Phase 2 Completed

40 enrolled 14 charts

Prostatic Neoplasms

NCT00026754 2025-04-18

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

19,522 enrolled

BreastDermatologicGenitourinarySarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms, Sarcoma, Skin Diseases, HIV Infections

NCT03436745 2025-02-11

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Phase 1 Completed

12 enrolled 11 charts

Sleep Initiation and Maintenance Disorders, Prostatic Neoplasms

NCT01638533 2025-02-07

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Phase 1 Completed

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryHead & NeckLymphoidNETOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Glioma, Lung Neoplasms, Lymphoma, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Neuroendocrine Tumors, Hematologic Neoplasms

NCT02362464 2024-12-10

Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

Phase 2 Completed

14 enrolled 14 charts

Prostatic Neoplasms

NCT00341939 2024-06-13

Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data

BreastDermatologicGenitourinaryLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT02933255 2024-05-31

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

Phase 1/2 Completed

24 enrolled 20 charts

Prostatic Neoplasms

NCT00020046 2023-10-31

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

NCT00942331 2023-10-16

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Phase 3 Completed

506 enrolled 13 charts

Carcinoma, Transitional Cell, Prostatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT01867333 2023-09-26

Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer

Phase 2 Completed

57 enrolled 14 charts

Prostatic Neoplasms

NCT00001503 2023-06-18

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

BreastDermatologicGenitourinaryGynecologicLymphoid

Breast Neoplasms, Lymphoma, Melanoma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT02649439 2022-11-14

Prostvac in Patients With Biochemically Recurrent Prostate Cancer

Phase 2 Completed

97 enrolled 16 charts

Prostatic Neoplasms

NCT00972309 2022-10-12

A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

Phase 1 Completed

41 enrolled 15 charts

Prostatic Neoplasms

NCT01377753 2022-02-01

MR Image Guided Therapy in Prostate Cancer

Phase 2 Completed

15 enrolled 12 charts

Prostatic Neoplasms

NCT03481816 2021-05-19

Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines

Phase 1 Completed

18 enrolled 19 charts

Prostatic Neoplasms

NCT02179515 2021-01-26

Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)

Phase 1 Completed

38 enrolled 20 charts

BreastGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT00340600 2020-11-16

Continuation of Follow-up of DES-Exposed Cohorts

10,805 enrolled

BreastGenitourinaryGynecologic

Autoimmune Diseases, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT01576172 2020-11-12

Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

159 enrolled 12 charts

Prostatic Neoplasms

NCT01875250 2020-09-16

Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer

Phase 2 Completed

38 enrolled 15 charts

Prostatic Neoplasms

NCT03384316 2020-09-09

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Phase 1 Completed

11 enrolled 18 charts

BreastGastrointestinalGenitourinaryThoracic

Adenoviridae Infections, Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms

NCT00342771 2020-08-14

An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian Males

Prostatic Neoplasms, Tobacco Use

NCT00064129 2020-07-30

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT01867424 2020-07-08

Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

Phase 2 Completed

24 enrolled 11 charts

Prostatic Neoplasms

NCT02948413 2020-05-26

Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials

GenitourinaryLymphoidOther hematologic neoplasmOther solid neoplasmThoracic

Leukemia, Lymphoma, Mesothelioma, Neoplasms, Prostatic Neoplasms

NCT00339534 2020-05-20

Survey of Prostate Cancer in Accra, Ghana

Neoplasms, Prostatic Neoplasms

NCT00339664 2020-03-30

Analyses of Human Samples Collected in Clinical Trials

GenitourinaryOther hematologic neoplasm

Leukemia, Lymphoid, Leukemia, Myeloid, Neoplasm Metastasis, Prostatic Neoplasms

NCT00001469 2020-03-16

Genetic Analysis of Hereditary Prostate Cancer

Prostate cancer, familial, Adenocarcinoma, Prostatic Neoplasms

NCT02095145 2020-02-05

Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Phase 2 Completed

38 enrolled 37 charts

Prostatic Neoplasms

NCT00450749 2019-12-18

Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

Phase 2 Completed

10 enrolled 6 charts

Prostatic Neoplasms

NCT00113984 2019-12-16

Vaccine and Antibody Treatment of Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT00924092 2019-12-12

An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...

Phase 1 Completed

BreastGastrointestinalGenitourinaryHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00032825 2019-11-21

Ketoconazole Plus Docetaxel to Treat Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT01176526 2019-11-13

The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis

Prostatic Neoplasms

NCT01683994 2019-11-08

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Phase 1/2 Completed

49 enrolled 18 charts

Prostatic Neoplasms

NCT02141490 2019-09-06

Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

Phase 2 Completed

43 enrolled 12 charts

Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms

NCT00214422 2019-07-19

Intensity Modulated Radiation Therapy for Prostate Cancer

Phase EARLY_PHASE1 Completed

19 enrolled 15 charts

Neoplasms, Prostatic Neoplasms

NCT01026623 2019-06-17

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Phase 1/2 Completed

16 enrolled 12 charts

Prostatic Neoplasms

NCT02190279 2019-04-23

18F-DCFBC PET/CT in Prostate Cancer

Phase EARLY_PHASE1 Completed

116 enrolled 23 charts

Prostatic Neoplasms

NCT01553188 2019-03-05

AMG 386 and Abiraterone for Advanced Prostate Cancer

Phase 2 Completed

36 enrolled 18 charts

Prostatic Neoplasms